China Health Group Inc. (HKG:8225)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.135
-0.002 (-1.46%)
Apr 29, 2026, 3:52 PM HKT
-10.00%
Market Cap 134.37M
Revenue (ttm) 31.79M
Net Income (ttm) -16.65M
Shares Out 995.35M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 80,000
Average Volume 101,000
Open 0.135
Previous Close 0.137
Day's Range 0.135 - 0.135
52-Week Range 0.122 - 0.198
Beta -0.40
RSI 48.15
Earnings Date Mar 30, 2026

About China Health Group

China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers phar... [Read more]

Sector Healthcare
Founded 1998
Employees 32
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8225
Full Company Profile

Financial Performance

In 2025, China Health Group's revenue was 28.56 million, an increase of 7.98% compared to the previous year's 26.45 million. Losses were -14.96 million, 3.05% more than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.